Literature DB >> 8565769

Increased resting lipid oxidation in Crohn's disease.

G Mingrone1, A V Greco, G Benedetti, E Capristo, R Semeraro, G Zoli, G Gasbarrini.   

Abstract

Resting energy expenditure (REE) was measured by indirect calorimetry and body composition was assessed by both direct (bioimpedance) and indirect (anthropometry) methods in 20 hospitalized patients with biopsy-proven ileal Crohn's disease and in a group of 16 healthy volunteers matched for sex, age, and height with the patient group. The Crohn's disease activity index was below 120 in all patients studied, who were treated with a low dose of corticosteroids (0.2-0.3 mg/kg body wt of prednisone). The average weight of Crohn's patients was significantly lower than that of controls (55.70 vs 70.50 kg, P < 0.001) due to both lower fat mass (9.97 vs 18.30 kg, P < 0.001) and lower lean body mass (45.72 vs 52.20 kg, P < 0.02). The average REE was significantly higher in the control group (1785.42 +/- 7.503 vs 1559.1 +/- 48.39 kcal/day, P < 0.001). However, these differences disappeared when REE was normalized by lean body mass (LBM) (34.49 +/- 2.56 vs 34.704 +/- 3.75 kcal/kg LBM P = NS). The nonprotein respiratory quotient was significantly lower in the patient group (0.823 +/- 0.031 vs 0.882 +/- 0.012, P < 0.025), indicating an increased lipid oxidation. This increased lipid oxidation might explain the reduced fat stores found in the group of Crohn's patients, suggesting also that a sufficiently lipid-rich diet could be useful in their nutritional management.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565769     DOI: 10.1007/bf02208586

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Relationship between total body water and surface area in normal and obese subjects.

Authors:  R Hume; E Weyers
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

2.  Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique.

Authors:  M A Stokes; G L Hill
Journal:  JPEN J Parenter Enteral Nutr       Date:  1993 Jan-Feb       Impact factor: 4.016

3.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

4.  Are patients with liver cirrhosis hypermetabolic?

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Nutr       Date:  1994-06       Impact factor: 7.324

5.  Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis.

Authors:  K Nielsen; J Kondrup; L Martinsen; B Stilling; B Wikman
Journal:  Br J Nutr       Date:  1993-05       Impact factor: 3.718

6.  Reduced metabolic efficiency in patients with Crohn's disease.

Authors:  M J Müller; L U Schmidt; J Körber; A von zur Mühlen; H Canzler; F W Schmidt
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

7.  Caloric requirements in patients with inflammatory bowel disease.

Authors:  L R Barot; J L Rombeau; I D Feurer; J L Mullen
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

8.  Resting and total energy expenditure in patients with inflammatory bowel disease.

Authors:  R F Kushner; D A Schoeller
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

9.  Estimated versus measured basal energy requirements in patients with Crohn's disease.

Authors:  A T Chan; C R Fleming; W M O'Fallon; K A Huizenga
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

10.  Effects of dexfenfluramine on free fatty acid turnover and oxidation in obese patients with type 2 diabetes mellitus.

Authors:  A V Greco; G Mingrone; E Capristo; A De Gaetano; G Ghirlanda; M Castagneto
Journal:  Metabolism       Date:  1995-02       Impact factor: 8.694

View more
  5 in total

Review 1.  Nutrition in inflammatory bowel disease.

Authors:  D G Kelly
Journal:  Curr Gastroenterol Rep       Date:  1999-08

2.  Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats.

Authors:  M Barbier; C Cherbut; A C Aubé; H M Blottière; J P Galmiche
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

3.  Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease.

Authors:  Nik Sheng Ding; Daniel Tassone; Ibrahim Al Bakir; Kyle Wu; Alexander J Thompson; William R Connell; George Malietzis; Phillip Lung; Siddharth Singh; Chang-Ho Ryan Choi; Simon Gabe; John T Jenkins; Ailsa Hart
Journal:  J Crohns Colitis       Date:  2022-09-08       Impact factor: 10.020

4.  Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration.

Authors:  Dawesh P Yadav; Saurabh Kedia; Kumble Seetharama Madhusudhan; Sawan Bopanna; Sandeep Goyal; Saransh Jain; Naval K Vikram; Raju Sharma; Govind K Makharia; Vineet Ahuja
Journal:  Can J Gastroenterol Hepatol       Date:  2017-10-31

Review 5.  Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Jie Dong; Yi Chen; Yuchen Tang; Fei Xu; Chaohui Yu; Youming Li; Prasoon Pankaj; Ning Dai
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.